Literature DB >> 10508481

High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.

H Bamba1, S Ota, A Kato, A Adachi, S Itoyama, F Matsuzaki.   

Abstract

Cyclooxygenase (COX)-2 is a possible molecular target for suppression of colon carcinogenesis by non-steroidal anti-inflammatory drugs (NSAIDs). However, the expression of COX-2 in human colonic tumors during the adenoma-carcinoma sequence has not been elucidated. In the present study, we examined immuno-histochemically the expression and localization of the COX-2 protein in human colonic adenomas and cancers. Twelve human colonic adenomas and 9 advanced cancers were studied. Immunoreactive COX-2 was predominantly and strongly expressed in sub-epithelial interstitial cells broadly present in the surface area of adenomas. The staining pattern of macrophages was similar to that observed for COX-2 in adenomas. Adjacent normal colonic mucosa was negative for COX-2 expression. In contrast, COX-2 was relatively weakly expressed in both tumor cells and interstitial cells in advanced colon cancers. In conclusion, the target of NSAIDs in preventing colon carcinogenesis may be the COX-2 expressed in interstitial cells, possibly macrophages, of colonic adenomas. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508481     DOI: 10.1002/(sici)1097-0215(19991112)83:4<470::aid-ijc6>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis.

Authors:  K H Hong; J C Bonventre; E O'Leary; J V Bonventre; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue.

Authors:  Harinder Garewal; Lois Ramsey; Ronnie Fass; Nancy K Hart; Claire M Payne; Harris Bernstein; Carol Bernstein
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.

Authors:  S Tanaka; A Tatsuguchi; S Futagami; K Gudis; K Wada; T Seo; K Mitsui; M Yonezawa; K Nagata; S Fujimori; T Tsukui; T Kishida; C Sakamoto
Journal:  Gut       Date:  2005-08-05       Impact factor: 23.059

4.  Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus.

Authors:  Hiroshi Yasuda; Masaya Yamada; Yutaka Endo; Kazuaki Inoue; Makoto Yoshiba
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

5.  PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas.

Authors:  Gerasimos P Vandoros; Panagiotis A Konstantinopoulos; Georgia Sotiropoulou-Bonikou; Athina Kominea; Georgios I Papachristou; Michalis V Karamouzis; Maria Gkermpesi; Ioannis Varakis; Athanasios G Papavassiliou
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-08       Impact factor: 4.553

6.  IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.

Authors:  Min Fang; Yongkui Li; Kai Huang; Shanshan Qi; Jian Zhang; Witold Zgodzinski; Marek Majewski; Grzegorz Wallner; Stanislaw Gozdz; Pawel Macek; Artur Kowalik; Marcin Pasiarski; Ewelina Grywalska; Linda Vatan; Nisha Nagarsheth; Wei Li; Lili Zhao; Ilona Kryczek; Guobin Wang; Zheng Wang; Weiping Zou; Lin Wang
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

7.  Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.

Authors:  N Banu; A Buda; S Chell; D Elder; M Moorghen; C Paraskeva; D Qualtrough; M Pignatelli
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

8.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2.

Authors:  Hiroshi Nishihara; Shinae Kizaka-Kondoh; Paul A Insel; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-01       Impact factor: 11.205

Review 9.  Cyclooxygenase-2 and its role in colorectal cancer development.

Authors:  Dominique Wendum; Joëlle Masliah; Germain Trugnan; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-09-01       Impact factor: 4.064

10.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.